| 22211042 | Suppression of Host Innate Immune Response by severe respiratory syndrome coronavirus 2 ORF3a protein via Induction of IKKε dependent autophagy | 1386852 | 2023 |
| 20190742 | Discovery of a novel SARS-CoV-2 cell entry mechanism mediated by circulating soluble ACE2 (sACE2): potential therapeutic target and risk marker for COVID-19 | 1113540 | 2020 |
| 21200512 | First detection of pandemic clone Salmonella ST34-carrying mcr-3: prevalence and characteristics of multidrug resistant Salmonella isolated from humans and foods in Hong Kong | 1500000 | 2021 |
| 21200432 | Type I Interferon antagonism of severe respiratory syndrome coronavirus 2 NSP5 protein | 1351852 | 2021 |
| COVID190114 | Development and test of candidate attenuated vaccines for SARS-CoV-2 | 3000000 | 2019 |
| C7142-20G | Mechanism of inflammasome activation by SARS-CoV-2 | 8431247 | 2020 |
| T11-709/21-N | Ecology, molecular virology and pathogenesis of SARSCoV-2: From bedside to bench and back | 31136000 | 2021 |
| 15140762 | Efficacy and mechanistic evaluation of banana lectin (BanLec) as a novel pan-coronavirus antiviral agent: in-vitro and ex-vivo evidence | 731296 | 2015 |
| T11-707/15-R | Molecular Basis for Interspecies Transmission and Pathogenesis of Middle East Respiratory Syndrome Coronavirus | 35620000 | 2015 |
| 14130822 | Suppression of innate interferon production by Middle East respiratory syndrome coronavirus M protein | 1000000 | 2014 |
| COVID1903010 | Preparing for COVID-19 upcoming challenges by clinical and virological investigations | 33523365 | 2021 |
| C7011-15R | Molecular Mechanism of PACT-dependent Innate Antiviral Response | 7555731 | 2015 |
| CID-HKU1 | Research for the control of emerging or important acute microbial infections with public health threat to HKSAR | 28000000 | 2020 |
